Mitomycin-C as a Preventive Measure of Adhesion after Functional Endoscopic Sinus Surgery (FESS) | ||
| Egyptian Journal of Ear, Nose, Throat and Allied Sciences | ||
| Article 8, Volume 21, Issue 3, November 2020, Pages 154-158 PDF (949.32 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejentas.2020.26708.1189 | ||
| Authors | ||
| Fatma Mohamed Elhussieny1; Doaa Abd Elhalim Saif Eldin1; Yasmin Ahmed Elsharawy2 | ||
| 1Department of ENT, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt. | ||
| 2Drug and Poison Information Center, Pharmacy Department, King Saud University Medical City, Riyadh, Saudi Arabia. | ||
| Abstract | ||
| Background: Synechia formation in a postoperative nasal cavity is a major factor for suboptimal clinical outcome in functional endoscopic sinus surgery (FESS). Nasal packs medicated with topical agents like mitomycin C have been shown to reduce the formation of synechiae in postoperative patients. Aim: To assess the role of mitomycin-c (MMC) in preventing synechia formation and ostial stenosis following endoscopic nasal surgery. Patients and Methods: This is a prospective comparative study performed at the department of Otorhinolaryngology, El-Zhraa University hospital from January 2018 to December 2019 to evaluate the effect of MMC in prevention of nasal adhesions after endoscopic nasal surgery. A total of fifty (50) patients of different age groups and both sexes were involved in the study and divided into two groups, each group include 25 patients, group A with applying MMC and group B without applying MMC. Results: In the MMC group, there was a reduction of synechia and crustration formation in group A that use MMC than group B without using MMC but with no significance. Conclusion: Mitomycin C (MMC) is safe and beneficial in decreasing adhesion formation after endoscopic nasal surgery. | ||
| Keywords | ||
| Endoscopic nasal surgery; FESS; mitomycin-C | ||
|
Statistics Article View: 461 PDF Download: 738 |
||
